Latest Breaking News On - Sharon merrill associates inc - Page 21 : comparemela.com

AIM ImmunoTech Postpones Investor Conference Call. Will Reschedule for a Later Date AIM ImmunoTech Postpones Investor Conference Call. Will Reschedule for a Later Date OCALA, Fla., Jan. 11, 2021 AIM ImmunoTech Inc. (NYSE American: AIM) and its CEO Thomas K. Equels today announced that this week’s planned investor conference call will be postponed and rescheduled for a later date following the death of Mr. Equels’ mother over this past weekend. About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

New yorkUnited statesDavid mcmullinScott solomonSharon merrill associates incOppenheimer coExchange commissionEquity syndicate prospectus departmentAldeyra therapeutics incSecurities exchangeSyndicate departmentAldeyra therapeuticsOne federal streetScavenger receptorSecurities exchange actRisk factors